共 345 条
[11]
Kim KT(2018)Fertility-preserving treatment in young women with grade 1 presumed stage IA endometrial adenocarcinoma: a meta-analysis Int J Gynecol Cancer 28 385-17
[12]
Saso S(2018)Treatment of low-risk endometrial Cancer and complex atypical hyperplasia with the Levonorgestrel-releasing intrauterine device Obstet Gynecol 131 109-968
[13]
Chatterjee J(1983)Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 10-246
[14]
Georgiou E(1997)Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas Mod Pathol 10 963-412
[15]
Ditri AM(1987)Endometrial carcinoma: two diseases? Cancer Detect Prev 10 237-138
[16]
Smith JR(1985)The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients Cancer 56 403-478
[17]
Ghaem-Maghami S(1993)Combined estrogen and progesterone use and endometrial cancer Epidemiology 4 384-978
[18]
Sherman ME(2004)Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review Gynecol Oncol 95 133-440
[19]
Temkin SM(2012)Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium Arch Gynecol Obstet 285 473-327
[20]
Minasian L(2007)Hormone therapy in advanced and recurrent endometrial cancer: a systematic review Int J Gynecol Cancer 17 964-73